1 Min Read
STOCKHOLM, April 8 (Reuters) - H Lundbeck A/S : * Lundbeck presents new data on selincro from three phase III studies that
consistently show a significant reduction in alcohol consumption in alcohol
dependent patients with high risk drinking level
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.